Suchergebnisse - "Gambino, Angela"

PubPharm (21)

1

Response to Chemotherapy and Clinical Outcome of Patients With Recurrent Epithelial Ovarian Cancer After PARP Inhibitor Maintenance Treatment : A Multicenter Retrospective Italian Study

enthalten in: Anticancer research | 2022

von Gadducci, A. | Cosio, S. | Landoni, F. | +6

2

VEGF-D Serum Level as a Potential Predictor of Lymph Node Metastasis and Prognosis in Vulvar Squamous Cell Carcinoma Patients

enthalten in: Frontiers in oncology | 2022

von Ravaggi, A. | Gambino, A. | Ferrari, F. | +12

3

Validation of Androgen Receptor loss as a risk factor for the development of brain metastases from ovarian cancers

enthalten in: Journal of ovarian research | 2020

von Mittica, G. | Goia, M. | Gambino, A. | +16

4

Validation of Androgen Receptor loss as a risk factor for the development of brain metastases from ovarian cancers

enthalten in: Journal of ovarian research | 2020

von Mittica, G. | Goia, M. | Gambino, A. | +16

5

Validation of Androgen Receptor loss as a risk factor for the development of brain metastases from ovarian cancers

enthalten in: Journal of ovarian research | 2020

von Mittica, G. | Goia, M. | Gambino, A. | +16

6

Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients

enthalten in: Frontiers in oncology | 2020

von Romani, C. | Zizioli, V. | Silvestri, M. | +16

7

FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients

enthalten in: British journal of cancer | 2019

von Tassi, R. | Gambino, A. | Ardighieri, L. | +12

8

The Rare Extragonadal Omental Teratoma : A Case Report

enthalten in: Journal of minimally invasive gynecology | 2017

von Rampinelli, F. | Donarini, P. | Visenzi, C. | +3

9

RERT : A Novel Regression Tree Approach to Predict Extrauterine Disease in Endometrial Carcinoma Patients

enthalten in: Scientific reports | 2017

von Vezzoli, M. | Ravaggi, A. | Zanotti, L. | +8

10

Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma : A validation across two independent cohorts

enthalten in: Cancer letters | 2017

von Todeschini, P. | Salviato, E. | Paracchini, L. | +20